How The Royalty Pharma (RPRX) Story Is Shifting With New Deals And Updated Expectations [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Royalty Pharma's updated fair value price target now sits at US$51.56, compared with the previous US$51.00 level. Analysts linking this shift to current Street commentary point to optimism around the royalty portfolio and deal structuring, while still flagging execution and deal flow as areas to watch. As you read on, you will see how these moving pieces feed into the evolving narrative and what to keep an eye on as sentiment changes. Stay updated as the Fair Value for Royalty Pharma shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Royalty Pharma. What Wall Street Has Been Saying ?? Bullish Takeaways TD Cowen lifted its Royalty Pharma price target to US$50, pointing to what it sees as strengths in the biopharma royalty market, the company's differentiation from peers, and the breadth of its portfolio. These factors feed into the firm's updated model and valuation work. Evercore ISI highlighted the US$2
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Royalty Pharma Appoints Lucas Glass as Head of Artificial IntelligenceGlobeNewswire
- Royalty Pharma Announces Expansion of Leadership Team [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma Announces Expansion of Leadership TeamGlobeNewswire
- Royalty Pharma plc (RPRX) Earns $51 Target as 2026 Growth Outlook Exceeds Expectations [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma plc (RPRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
RPRX
Sec Filings
- 3/23/26 - Form 144
- 3/19/26 - Form 144
- 3/18/26 - Form 144
- RPRX's page on the SEC website